Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4

Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4
Bhang To Acquire Patents And IP For Canabinoid And Psychedelics-Infused Musocal Strips And Biphasic Edibles – Bhang (OTC:BHNGF) – Stocks to Watch
  • Fri. May 3rd, 2024

Bhang To Acquire Patents And IP For Canabinoid And Psychedelics-Infused Musocal Strips And Biphasic Edibles – Bhang (OTC:BHNGF)

ByVuk Zdinjak

Mar 7, 2023
Bhang To Acquire Patents And IP For Canabinoid And Psychedelics-Infused Musocal Strips And Biphasic Edibles - Bhang (OTC:BHNGF)

[ad_1]

Bhang Inc. BHNGF BHNG has signed a letter of intent to acquire 1352135 B.C. Ltd. (“BC Corp“) to obtain access to minor-cannabinoid, cannabis, THC, and psychedelic-related patents and intellectual property pivotal in building Bhang’s portfolio beyond chocolate and edible cannabis brands.

“We are innovating new products and proprietary delivery methods designed to enhance and complement consumer happiness, lifestyle, and well-being,” stated Graham Simmonds, Bhang’s interim CEO. “This proposed acquisition is an exciting step on that path, bringing new IP into the Bhang portfolio, and putting us in a position to leverage our global brand recognition with new revenue streams from both existing and new distribution platforms.”

The patents and IP that are available to BC Corp. through certain exclusive licensing agreements include mucosal strips and biphasic edibles, which are new delivery methods and formulations for THC, minor cannabinoids, and psychedelic-infused edible products.

Pursuant to the LOI, the company would acquire all of the issued and outstanding common shares of BC Corp on or before March 10, 2023. In consideration for the acquisition, the company would issue to the vendors of BC Corp. CA$1 million in subordinate voting shares of Bhang at a price of CA$0.05 per subordinate voting share. The closing of the acquisition is subject to the approval of Bhang’s board of directors, and pending the results of any due diligence and approvals required by any applicable regulatory body.

Benzinga’s Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo: Benzinga edit with photos by jarmoluk and lindsayfox on Pixabay

[ad_2]

Image and article originally from www.benzinga.com. Read the original article here.